10 results were returned
International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")
The capital markets experts based in London have advised on four placings which closed within the same week
The excitement around the potential for the UK cannabis market – medicinal and nutritional – to continue opening up has really intensified in the first half of 2019.
International law firm Bird & Bird today expands its Corporate practice group with the appointment of James Baillieu as a partner in London.
Yesterday (20 April 2020) the UK Government announced a scheme pledging £1 billion worth of support for start-ups struggling amidst the Coronavirus pandemic who are likely to be ineligible for the Government's emergency ...
The UK Financial Conduct Authority issues its first formal decision under the competition enforcement powers it was given in 2015. We look at the decision in more detail and its implication for market participants.
The UK government has given the Competition and Markets Authority (CMA) further powers to review mergers in strategically important sectors. These steps include making changes to the Enterprise Act 2002 to provide the ...
The London Stock Exchange has issued a disciplinary notice which highlights the importance of an AIM company needing to follow the guidance that has been given to it by its nominated adviser. We look at the implications ...
AIM companies must now disclose details of the recognised corporate governance code that it has adopted, how the company complies with this code or, where it departed from this code, an explanation of the reasons for ...
In the fall of next year, the long anticipated EU Foreign Direct Investment Screening Regulation will apply. The regulation is likely to have a significant impact on FDI within the EU – both within Member States that ...